0.20Open0.20Pre Close0 Volume2 Open Interest2.50Strike Price0.00Turnover2399.49%IV332.00%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.5117Delta0.3765Gamma3.13Leverage Ratio-0.1311Theta0.0000Rho1.60Eff Leverage0.0002Vega
Equillium Stock Discussion
is this stock still even alive
$Equillium (EQ.US)$
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, recently announced promising topline results from its Phase 2 proof-of-concept (PoC) study of EQ101 in adult patients suffering from moderate, severe, or very-severe alopecia areata (AA). This autoimmune condition, driven by an immune cell attack on hair follicles, leads...
No comment yet